Norway Upstream Bioprocessing Market Size & Outlook
Norway upstream bioprocessing market, 2018-2030 (US$M)
Related Markets
Norway upstream bioprocessing market highlights
- The Norway upstream bioprocessing market generated a revenue of USD 163.2 million in 2023 and is expected to reach USD 350.9 million by 2030.
- The Norway market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
- In terms of segment, bioreactors/fermenters was the largest revenue generating product in 2023.
- Cell Culture Products is the most lucrative product segment registering the fastest growth during the forecast period.
Upstream bioprocessing market data book summary
| Market revenue in 2023 | USD 163.2 million |
| Market revenue in 2030 | USD 350.9 million |
| Growth rate | 11.6% (CAGR from 2023 to 2030) |
| Largest segment | Bioreactors/fermenters |
| Fastest growing segment | Cell Culture Products |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
Other key industry trends
- In terms of revenue, Norway accounted for 0.7% of the global upstream bioprocessing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany upstream bioprocessing market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 3,410.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Upstream Bioprocessing Market Scope
Upstream Bioprocessing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway upstream bioprocessing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 30.76% in 2023. Horizon Databook has segmented the Norway upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden has a presence of numerous bioprocessing companies, such as Getinge and Cellevate AB. These companies regularly undertake several business initiatives, such as product launches, partnerships, product advancements, and geographic expansions, to gain maximum market share. These initiatives are expected to boost the upstream bioprocessing market growth in Sweden.
For instance, in December 2023, Cellevate AB, a biotech firm specializing in next-generation cell culture systems designed to revolutionize biomanufacturing, inaugurated its new and larger premises in Lund, Sweden. The event’s highlight was the official commencement of the internal upstream bioprocessing cell culture establishment.
Reasons to subscribe to Norway upstream bioprocessing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway upstream bioprocessing market databook
-
Our clientele includes a mix of upstream bioprocessing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Norway upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway upstream bioprocessing market size, by product, 2018-2030 (US$M)
Norway Upstream Bioprocessing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
